PHARMACEUTICAL DOSAGE FORMS FOR (+)-1,4-DIHYDRO-7-[(3S,4S)-3-METHOXY-4-(METHYLAMINO)-1-PYRROLIDINYL]-4-OXO-1-(2-THIAZOLYL)-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACID

摘要

Provided herein are light protective pharmaceutical packages for enantiomerically pme (+)-l,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylarnino)-l-pyrrolidinyl]-4-oxo-l-(2- thiazolyl)-l,8-naphthyridine-3-carboxylic acid. In certain embodiments, the pharmaceutical packages comprise a glass vial containing SNS-595 drug product within a secondary container.